Finished
Randomized Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy
NCT04120805 · University of Chicago · Updated 21 Oct 2026
- What is being tested
- Hemostatic Agent; No Hemostatic Agent
- For
- Kidney Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 208 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 Jan 2016, ends 18 Nov 2025. Registered 9 Oct 2019.
- Results
- Posted on the registry on 21 Oct 2026.
In the researchers' words
The purpose of this study is to evaluate the necessity of using hemostatic agents as a tool when performing robotic partial nephrectomy in the treatment of kidney cancer. This project asks whether patients who undergo robotic partial nephrectomy without the surgeon using hemostatic agents during the procedure will have the same, fewer, or more complications than when patients undergo this same surgery with the surgeon using hemostatic agents during the procedure.
Sites
- The University of ChicagoChicago, Illinois, United States
